We are live on
!
Find out more
PAND
Pandion Therapeutics Inc. Common Stock
PAND
PAND
Delisted
PAND was delisted on the 31st of March, 2021.
75 hedge funds and large institutions have $515M invested in Pandion Therapeutics Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
226% more capital invested
Capital invested by funds: $158M → $515M (+$357M)
193% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 14
133% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 9
56% more funds holding
Funds holding: 48 → 75 (+27)
Holders
75
Holders Change
+27
Holders Change %
+56.25%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
21
Reduced
9
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$27.9M |
| 2 |
VI
Versor Investments
New York
|
+$26.9M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$26.2M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$18.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$14.6M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$34.5M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$31.3M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$26.3M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$20.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.9M |
